Jacob M. Rae

Since joining Kirkland, Jacob has been involved in the following matters:

• Representing Honeywell and certain of its officers and directors in a putative securities class action and shareholder derivative litigation filed in New Jersey and Delaware federal courts concerning Honeywell’s accounting for asbestos-related liabilities.
• Representing Mindbody and its portfolio parent, Vista Equity Partners, in a putative securities class action, shareholder litigation, and an appraisal action filed in New York federal court and Delaware Chancery Court challenging Vista’s $1.9 billion take-private acquisition of Mindbody.
• Representing cryptocurrency company and its officers in a shareholder derivative action in the Delaware Chancery Court alleging breach of fiduciary duty and related claims arising from a multi-billion dollar corporate transaction.
• Represented JELD-WEN and certain of its officers and directors in a securities class action litigation filed in Virginia federal court arising from price-fixing allegations and related lawsuits. Settlement achieved in 2021.
• Represented a private investment firm in a $100 million dispute brought by a terminated former partner alleging more than a dozen contractual and equitable claims. Tried to verdict. The arbitration panel denied all of the former partner’s claims for damages and found that he was in breach and had to return millions in escrowed severance.
• Represented Teva and Amneal Pharmaceuticals in a case alleging an anti-competitive horizontal conspiracy arising out of patent litigation settlements concerning the gout drug Colcrys® (colchicine).
• Represented Honeywell in a putative securities class action litigation filed in Minnesota federal court relating to the financial results for Resideo Technologies, which was spun-off from Honeywell. Honeywell was dropped as a defendant.
• Represented Honeywell officer, who was a pre-spin Garret Motion director and officer, in a putative securities class action litigation filed in New York federal court relating to the financial obligations of Garrett Motion, which was spun-off from Honeywell. The claims were dismissed with prejudice.
• Represented Liqui-Box, a portfolio company of Olympus Partners, and Olympus Partners in litigation filed in New York federal court arising from Liqui-Box’s $585 million acquisition of the plastics division of D.S. Smith.
• Represented non-profit New York hospital in litigation filed in New York Supreme Court relating to the proceeds of the demutualization of MLMIC Insurance Company following Berkshire Hathaway’s $2.5 billion acquisition of MLMIC.
• Represented J.C. Flowers in a dispute filed in New York federal court arising out of the purchase of HSH Nordbank AG.

Prior to joining Kirkland, Jacob was involved in the following matters:

• Represented aerospace and defense company in fraud and breach of contract action in the Southern District of New York against former owners of an acquired company.
• Represented a Fortune Global 500 company in related actions alleging violations of the Resource Conservation and Recovery Act and personal injuries from groundwater contamination related to a former industrial site. In August 2018 the Northern District of Indiana denied plaintiffs’ motion for class certification.
• Represented leading U.S. pharmaceutical manufacturer in reaching a successful conclusion in Hatch-Waxman litigation against a generic competitor.
• Represented international insurers in insurance arbitration regarding losses stemming from toxic chemical pollution claims.
• Represented major international law firm in connection with an action in New York Supreme Court alleging professional malpractice. The court dismissed all claims as barred by the statute of limitations.

Norton Rose Fulbright US LLP

Chadbourne & Parke LLP